Retinoic acid syndrome during the treatment of acute myelomonocytic leukaemia with all-trans-retinoic acid and low-dose cytosine arabinoside.
Nagafuji
K
K
Eto
T
T
Tokunaga
Y
Y
Hayashi
S
S
Niho
Y
Y
D003561:Cytarabine / Q000627:therapeutic use*; D006801:Humans; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy*; D007958:Leukocyte Count; D007964:Leukocytosis / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D013577:Syndrome; D014212:Tretinoin / Q000009:adverse effects*
D003561:Cytarabine; D014212:Tretinoin